二甲双胍对大鼠肾小球系膜细胞NF-κB、MCP-1、ICAM-1表达及合成的影响

来源 :安徽医科大学学报 | 被引量 : 0次 | 上传用户:judge119
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
目的观察二甲双胍对大鼠肾小球系膜细胞(MCs)核因子-κB(NF-κB)、单核细胞趋化蛋白-1(MCP-1)、细胞间黏附分子-1(ICAM-1)表达及合成的影响,探讨其对肾脏的保护机制。方法体外培养MCs,随机分为正常糖组(NG)、高糖组(HG)及高糖+不同浓度二甲双胍组(M1、M2、M3)。培养48 h后收集各组细胞及上清液,采用荧光实时定量聚合酶链式反应(Real-time PCR)法检测细胞NF-κB、MCP-1及ICAM-1的mRNA含量;采用Western blot法检测细胞NF-κBp65及ICAM-1蛋白表达水平;采用ELISA法检测上清液中MCP-1蛋白浓度。结果①MCs可表达NF-κB、MCP-1和ICAM-1;②与NG组比较,HG组MCs NF-κB、MCP-1、ICAM-1的mRNA表达增强,NF-κBp65、ICAM-1及细胞上清液中MCP-1蛋白含量增高(P<0.05);③经二甲双胍干预后,高糖培养的MCs NF-κB、MCP-1及ICAM-1表达合成显著降低(P<0.05)。结论二甲双胍可抑制MCs NF-κB、MCP-1和ICAM-1的表达及合成,该作用可能与其肾脏保护机制有关。 Objective To observe the effects of metformin on the expression of NF-κB, MCP-1, ICAM-1 in rat mesangial cells (MCs) Expression and synthesis, to explore its mechanism of protection of the kidneys. Methods MCs were cultured in vitro and randomly divided into normal glucose group (NG), high glucose group (HG) and high glucose + metformin group (M1, M2, M3). After cultured for 48 h, the cells and supernatants of each group were collected, and the mRNA levels of NF-κB, MCP-1 and ICAM-1 were detected by Real-time PCR with fluorescence quantitative real-time PCR. The expression of NF-κBp65 and ICAM-1 protein in the cells was detected. The concentration of MCP-1 protein in the supernatant was detected by ELISA. Results ①MCs could express NF-κB, MCP-1 and ICAM-1. ② Compared with NG group, the mRNA expression of NF-κB, MCP-1 and ICAM-1 increased The content of MCP-1 in the supernatant increased (P <0.05). ③ The expression of NF-κB, MCP-1 and ICAM-1 in MCs cultured with high glucose was significantly decreased after metformin intervention (P <0.05). Conclusion Metformin can inhibit the expression and synthesis of NF-κB, MCP-1 and ICAM-1 in MCs, which may be related to the mechanism of renal protection.
其他文献
2019年12月11日-12日,由生态环境部环境与经济政策研究中心(以下简称政研中心)举办的第四届流域综合管理与农业面源污染治理研讨会在北京顺利召开。会议由政研中心环境法规与
期刊
期刊
证明了双循环半群上的任意正规子半群N都可以用B_d表示,同时也证明了正规子半群B_d构成的集合B是分配格.
期刊
期刊
ue*M#’#dkB4##8#”专利申请号:00109“7公开号:1278062申请日:00.06.23公开日:00.12.27申请人地址:(100084川C京市海淀区清华园申请人:清华大学发明人:隋森芳文摘:本发明属于生物技
本文立足于通信领域近年来备受关注的研究热点--可见光通信,阐述了其研究背景和基础系统架构,围绕材料器件、高速系统、异构网络、水下可见光通信和机器学习等五个前沿研究方